Socs-1 Inhibits TEL-JAK2-Mediated Transformation of Hematopoietic Cells through Inhibition of JAK2 Kinase Activity and Induction of Proteasome-Mediated Degradation

REFERENCES

• Carron, C., F. Cormier, A. Janin, V. Lacronique, M. Giovannini, M. T. Daniel, O. Bernard, and J. Ghysdael. 2000. TEL-JAK2 transgenic mice develop T-cell leukemia. Blood 95:3891–3899.
   PubMed Web of Science ®Google Scholar
• Chai, S. K., G. L. Nichols, and P. Rothman. 1997. Constitutive activation of JAKs and STATs in BCR-Abl expressing cell lines and peripheral blood cells derived from leukemic patients. J. Immunol. 159:4720–4728.
   PubMed Web of Science ®Google Scholar
• Chauhan, D., S. M. Kharbanda, T. Ogata, M. Urashima, D. Frank, N. Malik, D. W. Kufe, and K. C. Anderson. 1995. Oncostatin M induces association of Grb2 with Janus kinase JAK2 in multiple myeloma cells. J. Exp. Med. 182:1801–1806.
   PubMed Web of Science ®Google Scholar
• Daley, G. Q., R. A. Van Etten, and D. Baltimore. 1990. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 247:824–830.
   PubMed Web of Science ®Google Scholar
• David, M., E. Petricoin, C. Benjamin, R. Pine, M. J. Weber, and A. C. Larner. 1995. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. Science 269:1721–1723.
   PubMed Web of Science ®Google Scholar
• Eguchi, M., M. Eguchi-Ishimae, A. Tojo, K. Morishita, K. Suzuki, Y. Sato, S. Kudoh, K. Tanaka, M. Setoyama, F. Nagamura, S. Asano, and N. Kamada. 1999. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). Blood 93:1355–1363.
   PubMed Web of Science ®Google Scholar
• Endo, T. A., M. Masuhara, M. Yokouchi, R. Suzuki, H. Sakamoto, K. Mitsui, A. Matsumoto, S. Tanimura, M. Ohtsubo, H. Misawa, T. Miyazaki, N. Leonor, T. Taniguchi, T. Fujita, Y. Kanakura, S. Komiya, and A. Yoshimura. 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921–924.
   PubMed Web of Science ®Google Scholar
• Finer, M. H., T. J. Dull, L. Qin, D. Farson, and M. R. Roberts. 1994. kat: a high-efficiency retroviral transduction system for primary human T lymphocytes. Blood 83:43–50.
   PubMed Web of Science ®Google Scholar
• Frank, D. A., S. Mahajan, and J. Ritz. 1997. B. lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues. J. Clin. Investig. 100:3140–3148.
   PubMed Web of Science ®Google Scholar
• Golub, T. R., G. F. Barker, M. Lovett, and D. G. Gilliland. 1994. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77:307–316.
   PubMed Web of Science ®Google Scholar
• Golub, T. R., A. Goga, G. Barker, D. Afar, J. McLaughlin, S. Bohlander, J. Rowley, O. Witte, and D. G. Gilliland. 1996. Oligomerization of the ABL tyrosine kinase by the ETS protein TEL in human leukemia. Mol. Cell. Biol. 16:4107–4116.
   PubMed Web of Science ®Google Scholar
• Gouilleux-Gruart, V., F. Gouilleux-Gruart, C. Desaint, J. F. Claisse, J. C. Capoid, J. Delobel, R. Weber-Nordt, I. Dusanter-Fourrt, F. Dreyfus, B. Groner, and L. Prin. 1996. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood 87:1692–1697.
   PubMed Web of Science ®Google Scholar
• Hawley, R. G., F. H. L. Lieu, A. Z. C. Fong, and T. S. Hawley. 1994. Versatile retroviral vectors for potential use in mice by an interleukin 6 retrovirus. Gene Ther. 1:136–138.
   PubMed Web of Science ®Google Scholar
• Hilton, D. J., R. T. Richardson, W. S. Alexander, E. M. Viney, T. A. Willson, N. S. Sprigg, R. Starr, S. E. Nicholson, D. Metcalf, and N. A. Nicola. 1998. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA 95:114–119.
   PubMed Web of Science ®Google Scholar
• Ho, J. M., B. K. Beattie, J. A. Squire, D. A. Frank, and D. L. Barber. 1999. Fusion of the ets transcription factor TEL to Jak2 results in constitutive Jak-Stat signaling. Blood 93:4354–5364.
   PubMed Web of Science ®Google Scholar
• Hunter, T., and B. M. Sefton. 1980. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc. Natl. Acad. Sci. USA 77:1311–1315.
   PubMed Web of Science ®Google Scholar
• Ihle, J. N.. 1996. Signaling by the cytokine receptor superfamily in normal and transformed hematpoietic cells. Adv. Cancer Res. 68:23–65.
   PubMed Web of Science ®Google Scholar
• Ihle, J. N., and I. M. Kerr. 1995. Jaks and Stats in signaling by the cytokine receptor family. Trends Genet. 11:69–74.
   PubMed Web of Science ®Google Scholar
• Ilaria, R. L. J., and R. A. Van Etten. 1996. P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J. Biol. Chem. 271:31704–31710.
   PubMed Web of Science ®Google Scholar
• Johnson, G. R., T. J. Gonda, D. Metcalf, I. K. Hariharan, and S. Cory. 1989. A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte-macrophage colony stimulating factor. EMBO J. 8:441–448.
   PubMed Web of Science ®Google Scholar
• Lacronique, V., A. Boureux, R. Monni, S. Dumon, M. Mauchauffe, P. Mayeux, F. Gouilleux, R. Berger, S. Gisselbrecht, J. Ghysdael, and O. A. Bernard. 2000. Transforming properties of chimeric TEL-JAK2 proteins in Ba/F3 cells. Blood 95:2076–2083.
   PubMed Web of Science ®Google Scholar
• Lacronique, V., A. Boureux, V. D. Valle, H. Poirel, C. T. Quang, M. Mauchauffe, C. Berthou, M. Lessard, R. Berger, J. Ghysdael, and O. A. Bernard. 1997. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 278:1309–1312.
   PubMed Web of Science ®Google Scholar
• Lavau, C., S. J. Szilvassy, R. Slany, and M. L. Cleary. 1997. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J. 16:4226–4237.
   PubMed Web of Science ®Google Scholar
• Li, S., R. L. Ilaria Jr., R. P. Million, G. Q. Daley, and R. A. Van Etten. 1999. The P190, P210, and p230 forms of the BCR/ABL oncogene induce a similar chronic myeloid lerkemia-like syndrome in mice but have different lymphoid leukemogenic activity. J. Exp. Med. 189:1399–1412.
   PubMed Web of Science ®Google Scholar
• Liu, Q., J. Schwaller, J. Kutok, D. Cain, J. C. Aster, I. R. Williams, and D. G. Gilliland. 2000. Signal transduction and transforming properties of the TEL/TRKC fusions associated with t(12;15)p(13;q25) in congenital fibrosarcoma and acute myelogenous leukemia. EMBO J. 19:1827–1838.
   PubMed Web of Science ®Google Scholar
• Masuhara, M., H. Sakamoto, A. Matsumoto, R. Suzuki, H. Yasukawa, K. Mitsui, T. Wakioka, S. Tanimura, A. Sasaki, H. Misawa, M. Yokouchi, M. Ohtsubo, and A. Yoshimura. 1997. Cloning and characterization of novel CIS family genes. Biochem. Biophys. Res. Commun. 239:439–446.
   PubMedGoogle Scholar
• Matsumoto, A., M. Masuhara, K. Mitsui, M. Yokouchi, M. Ohtsubo, H. Misawa, A. Miyajima, and A. Yoshimura. 1997. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood 89:3148–3154.
   PubMed Web of Science ®Google Scholar
• Mayer, B. J., P. K. Jackson, and D. Baltimore. 1991. The noncatalytic src homology region 2 segment of abl tyrosine kinase binds to tyrosine-phosphorylated cellular proteins with high affinity. Proc. Natl. Acad. Sci. USA 88:627–631.
   PubMedGoogle Scholar
• Minamoto, S., K. Ikegame, K. Ueno, M. Narazaki, T. Naka, H. Yamamoto, T. Matsumoto, H. Saito, S. Hosoe, and T. Kishimoto. 1997. Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3. Biochem. Biophys. Res. Commun. 237:79–83.
   PubMed Web of Science ®Google Scholar
• Muda, M., U. Boschert, R. Dickinson, J. C. Martinou, I. Martinou, M. Camps, W. Schlegel, and S. Arkinstall. 1996. MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase. J. Biol. Chem. 8:19–26.
   Google Scholar
• Naka, T., M. Narazaki, M. Hirata, T. Matsumoto, S. Minamoto, A. Aono, N. Nishimoto, T. Kajita, T. Taga, K. Yoshizaki, S. Akira, and T. Kishimoto. 1997. Structure and function of a new STAT-induced STAT inhibitor. Nature 387:924–929.
   PubMed Web of Science ®Google Scholar
• Okuda, K., T. R. Golub, D. G. Gilliland, and J. D. Griffin. 1996. p210BCR/ABL, p190BCR/ABL amd TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines. Oncogene 13:1147–1152.
   PubMedGoogle Scholar
• Papadopoulos, P., S. A. Ridge, C. A. Boucher, C. Stocking, and L. M. Wiedemann. 1995. The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Res. 55:34–38.
   PubMed Web of Science ®Google Scholar
• Peeters, P., S. D. Raynaud, J. Cools, I. Wlodarska, J. Grosgeorge, P. Philip, F. Monpoux, L. Van Rompaey, M. Baens, H. Van den Berghe, and P. Marynen. 1997. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood 90:2535–2540.
   PubMed Web of Science ®Google Scholar
• Peeters, P., I. Wlodarska, M. Baens, A. Criel, D. Selleslag, A. Hagemeijer, H. Van den Berghe, and P. Marynen. 1997. Fusion of ETV6 to MDS1/EVI1 as a result of t(3;12)(q26;p13) in myeloproliferative disorders. Cancer Res. 57:564–569.
   PubMed Web of Science ®Google Scholar
• Persons, D. A., J. A. Allay, E. R. Allay, R. J. Smeyne, R. A. Ashmun, B. P. Sorrentino, and A. W. Nienhuis. 1997. Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood 90:1777–1786.
   PubMed Web of Science ®Google Scholar
• Pircher, T. J., A. Flores-Morales, A. L. Mul, A. R. Saltiel, G. Norstedt, J. A. Gustafsson, and L. A. Haldosen. 1997. Mitogen-activated protein kinase kinase inhibition decreases growth hormone stimulated transcription mediated by STAT5. Mol. Cell. Endocrinol. 133:169–176.
   PubMedGoogle Scholar
• Pircher, T. J., H. Petersen, J. A. Gustafsson, and L. A. Haldosen. 1999. Extracellular signal-regulated kinase (ERK) interacts with signal transducer and activator of transcription (STAT) 5a. Mol. Endocrinol. 13:555–565.
   PubMed Web of Science ®Google Scholar
• Sawyers, C. L.. 1999. Chronic myeloid leukemia. N. Engl. J. Med. 340:1330–1340.
   PubMed Web of Science ®Google Scholar
• Schwaller, J., J. Frantsve, M. Tomasson, J. Aster, I. Williams, L. Van Rompey, P. Marynen, R. Van Etten, R. Ilaria, and D. G. Gilliland. 1998. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myeloid and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion gene. EMBO J. 17:5321–5333.
   PubMed Web of Science ®Google Scholar
• Schwaller, J., E. Parganas, D. Wang, D. Cain, J. C. Aster, I. R. Williams, C.-K. Lee, R. Gerthner, T. Kitamura, J. Franstve, E. Anastasiadou, M. L. Loh, D. E. Levy, J. Ihle, and D. G. Gilliland. 2000. Stat5a/b is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. Mol. Cell 6:693–704.
   PubMed Web of Science ®Google Scholar
• Sexl, V., R. Piekorz, R. Moriggl, J. Rohrer, M. P. Brown, K. D. Bunting, K. Rothammer, M. F. Roussel, and J. N. Ihle. 2000. Stat5a/b contribute to interleukin1-induced B-cell precursor expansion, but abl and bcr/abl-induced transformation are independent of Stat5. Blood 96:2277–2283.
   PubMed Web of Science ®Google Scholar
• Starr, R., T. A. Willson, E. M. Viney, L. J. Murray, J. R. Rayner, B. J. Jenkins, T. J. Gonda, W. S. Alexander, D. Metcalf, N. A. Nicola, and D. J. Hilton. 1997. A family of cytokine-inducible inhibitors of signalling. Nature 387:917–921.
   PubMed Web of Science ®Google Scholar
• Wen, Z., Z. Zhong, and J. E. J. Darnell. 1995. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241–250.
   PubMed Web of Science ®Google Scholar
• Wilbanks, A. M., S. Mahajan, D. A. Frank, B. J. Druker, D. G. Gilliland, and M. Carroll. 2000. TEL/PDGFbetaR fusion protein activates STAT1 and STAT5: a common mechanism for transformation by tyrosine kinase fusion proteins. Exp. Hematol. 28:584–593.
   PubMedGoogle Scholar
• Winston, L. A., and T. Hunter. 1995. JAK2, Ras, and Raf are required for activation of extracellular signal-regulated kinase/mitogen-activated protein kinase by growth hormone. J. Biol. Chem. 270:30837–30840.
   PubMed Web of Science ®Google Scholar
• Yamashita, H., J. Xu, R. A. Erwin, W. L. Farrar, R. A. Kirken, and H. Rui. 1998. Differential control of the phosphorylation state of proline-juxtaposed serine residues Ser725 of Stat5a and Ser730 of Stat5b in prolactin-sensitive cells. J. Biol. Chem. 273:30218–30224.
   PubMedGoogle Scholar
• Yasukawa, H., H. Misawa, H. Sakamoto, M. Masuhara, A. Sasaki, T. Wakioka, S. Ohtsuka, T. Imaizumi, T. Matsuda, J. N. Ihle, and A. Yoshimura. 1999. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 18:1309–1320.
   PubMed Web of Science ®Google Scholar
• Zhang, J. G., A. Farley, S. E. Nicholson, T. A. Willson, L. M. Zugaro, R. J. Simpson, R. L. Moritz, D. Cary, R. Richardson, G. Hausmann, B. J. Kile, S. B. Kent, W. S. Alexander, D. Metcal, D. J. Hilton, N. A. Nicola, and M. Baca. 1999. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc. Natl. Acad. Sci. USA 96:2071–2076.
   PubMed Web of Science ®Google Scholar
• Zhang, X., J. Blenis, H. C. Li, C. Schindler, and S. Chen-Kiang. 1995. Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 267:1990–1994.
   PubMedGoogle Scholar
• Zhuang, H., S. V. Patel, T. He, S. K. Sonsteby, Z. Niu, and D. M. Wojchowski. 1994. Inhibition of erythropoietin-induced mitogenesis by a kinase-deficient form of JAK2. J. Biol. Chem. 269:21411–21414.
   PubMed Web of Science ®Google Scholar